Cite
HARVARD Citation
Deng, X. et al. (2022). Early response to upfront neoadjuvant chemotherapy (CAPOX) alone in low- and intermediate-risk rectal cancer: a single-arm phase II trial. British journal of surgery. 109 (1), pp. 121-128. [Online].